Seattle, WA · Founded 2021 · Privately Held (backing)
Developer of antibody-based therapeutics designed to enable targeted and regulated treatment of diseases. Bonum Therapeutics is based in Seattle, WA and was founded in 2021. Its last reported valuation was $130 million in Nov 2022. It has raised $127 million across 3 recorded rounds; the latest was a $26.9 million early-stage round in Apr 2026.
Last reported valuation
$130.0M
Oct 2026
Priced at
—
Total raised
$127.5M
Last round
Early Stage VC
Apr 2026
Cap table — not yet on record
Bonum Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bonum Therapeutics with a free account
·Watch Bonum Therapeutics: the Monday email on marks, rounds and moves
Where does Bonum Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Bonum Therapeutics's 3 recorded funding rounds.
